Effects of Eulophia macrobulbon Extract and Its Main Active Compound, 1-(4´-hydroxy-benzyl)-4,8-dimethoxyphenanthrene-2,7-diol on Hepatic Cytochrome P450 Activities in Rats
Trends in Sciences · 20.07.2026 · 23 (12) · 13925
DOI: 10.48048/tis.2026.13925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Sciences, online erschienen am 20.07.2026. Verfasst von Sutthinee Wisutthathum und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The Eulophia macrobulbon (EM) ethanolic extract and its active component, 1-(4´-hydroxy-benzyl)-4,8-dimethoxyphenanthrene-2,7-diol, have shown potential therapeutic benefits in the treatment of erectile dysfunction and cardiovascular diseases. However, their safety in relation to herb-drug interactions remains unclear. This study aimed to evaluate the potential for herb-drug interactions mediated by cytochrome P450 (CYP) modulation. CYP1A, CYP2B, CYP2C, and CYP3A activities were assessed in primary rat hepatocytes exposed to EM extract or phenanthrene, and in rat liver microsomes following 21-day oral administration. In vitro, EM extract decreased CYP2C activity and increased CYP1A and CYP3A activities, whereas phenanthrene showed no significant effects. In vivo, EM extract inhibited CYP2C and CYP3A activities at low doses (15 mg/kg) and induced CYP1A activity at higher doses (450 mg/kg), with no significant changes at 1,000 mg/kg. Phenanthrene decreased CYP1A activity at 750 µg/kg. Overall, CYP modulation was approximately 2-fold compared with the control. These findings indicate that EM extract can modulate key CYP enzymes and may pose a risk of herb-drug interactions, particularly through inhibition of CYP2C and CYP3A at low in vivo doses. The discrepancies between in vitro and in vivo results suggest that metabolites may contribute to CYP modulation. HIGHLIGHTS Cytotoxicity of EM extract and its phenanthrene was evaluated in primary rat hepatocytes. CYP1A, 2B, 2C, and 3A activities were assessed using in vitro and in vivo models. The EM extract and its phenanthrene modulated CYP isoforms, indicating a potential risk of herb-drug interactions. GRAPHICAL ABSTRACT
Zitieren
APA
Wisutthathum, S., Totoson, P., Chootip, K., Ingkaninan, K., Temkitthawon, P., Demougeot, C., & Martin, H. (2026). Effects of Eulophia macrobulbon Extract and Its Main Active Compound, 1-(4´-hydroxy-benzyl)-4,8-dimethoxyphenanthrene-2,7-diol on Hepatic Cytochrome P450 Activities in Rats. Trends in Sciences, 23(12), 13925. https://doi.org/10.48048/tis.2026.13925
Vancouver
Wisutthathum S, Totoson P, Chootip K, Ingkaninan K, Temkitthawon P, Demougeot C, et al. Effects of Eulophia macrobulbon Extract and Its Main Active Compound, 1-(4´-hydroxy-benzyl)-4,8-dimethoxyphenanthrene-2,7-diol on Hepatic Cytochrome P450 Activities in Rats. Trends in Sciences. 2026;23(12):13925. doi:10.48048/tis.2026.13925
BibTeX
@article{Wisutthathum2026,
author = {Wisutthathum, Sutthinee and Totoson, Perle and Chootip, Krongkarn and Ingkaninan, Kornkanok and Temkitthawon, Prapapan and Demougeot, Céline and Martin, Hélène},
title = {Effects of Eulophia macrobulbon Extract and Its Main Active Compound, 1-(4´-hydroxy-benzyl)-4,8-dimethoxyphenanthrene-2,7-diol on Hepatic Cytochrome P450 Activities in Rats},
journal = {Trends in Sciences},
year = {2026},
volume = {23},
number = {12},
pages = {13925},
doi = {10.48048/tis.2026.13925}
}
EUVIMED